| Purpose | Announcement Date | Ex-Date | Record Date | Dividend Amount | Dividend per Share | Remark |
|---|---|---|---|---|---|---|
| Dividend | 7 Aug 2025 | 12 Sep 2025 | 12 Sep 2025 | 3 | 150 | Final |
| Recommended a Final Dividend of Rs.3 (150%)per equity share of Rs.2 each for the financial year ended March 31, 2025. The said dividend, if approved at the forthcoming Annual General Meeting (AGM), shall be paid on or before October 21, 2025. | ||||||
| Dividend | 15 May 2025 | 30 May 2025 | 30 May 2025 | 3 | 150 | Interim |
| Declared an Interim Dividend of INR. 3.00 (150 %) per equity share of face value of INR. 2 each for the financial year ended March 31, 2025. | ||||||
The drug is the generic alternative of the Vitamin K1 Injection produced by Hospira Inc and is indicated in the treatment of Vitamin K deficiency-related coagulation disorders.
Here are some of the stocks that may see significant price movement today: ICICI Prudential, Caplin Point, Ashoka Buildcon, etc.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
